Home/Filings/4/0000930413-10-001907
4//SEC Filing

del Campo Ralph 4

Accession 0000930413-10-001907

CIK 0000727510other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 8:47 PM ET

Size

9.4 KB

Accession

0000930413-10-001907

Insider Transaction Report

Form 4
Period: 2010-04-03
del Campo Ralph
EVP, Technical Operations
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2010-04-0312,60016,800 total
    Exercise: $0.00From: 2010-04-03Exp: 2010-04-03Common Stock (12,600 underlying)
  • Tax Payment

    Common Stock

    2010-04-03$10.48/sh4,463$46,772158,759.136 total
  • Exercise/Conversion

    Common Stock

    2010-04-03+12,600163,222.136 total
Footnotes (3)
  • [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
  • [F2]The Reporting Person's beneficial ownership includes an aggregate of 2,500 shares of Common Stock purchased during the six months ended March 31, 2009 pursuant to the Issuer's 2007 Employee Stock Purchase Plan, which is exempt under Rule 16b-3(c).
  • [F3]Reporting Person used the proceeds of the disposition solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.

Documents

1 file

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001323683

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 8:47 PM ET
Size
9.4 KB